[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-460837-105":59,"doc-detail-460837-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","vaccination-as-a-key-determinant-of-influenza-disease-severity-in-allogeneic-hematopoietic-stem-cell-transplant-recipients-an-observational-retrospective-study","Vaccination as a Key Determinant of Influenza Disease Severity in Allogeneic Hematopoietic Stem Cell Transplant Recipients - An Observational Retrospective Study","","Influenza infection causes substantial morbidity in allogeneic hematopoietic stem cell transplant recipients, yet the clinical value of seasonal vaccination in this group has been insufficiently established. A retrospective, multicenter observational study assessed adult allo-HCT recipients with laboratory-confirmed influenza from 2013 to 2023, comparing vaccinated status defined by seasonal vaccine receipt before infection onset. Analysis of 214 episodes linked vaccination to reduced progression to lower respiratory tract disease and lower hospitalization risk.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/vaccination-as-a-key-determinant-of-influenza-disease-severity-in-allogeneic-hematopoietic-stem-cell-transplant-recipients-an-observational-retrospective-study/460837/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/vaccination-as-a-key-determinant-of-influenza-disease-severity-in-allogeneic-hematopoietic-stem-cell-transplant-recipients-an-observational-retrospective-study/460837.png","ImageObject",300,407,{"name":92,"@type":93},"\tCallum ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was vaccination status defined in the study?","Question",{"text":112,"@type":113},"Vaccinated status required receiving the seasonal influenza vaccine during the same season and before the onset of influenza infection.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What main outcomes were assessed to evaluate disease severity?",{"text":117,"@type":113},"The study evaluated progression to lower respiratory tract disease and hospitalization risk, alongside independent predictors such as immunodeficiency scoring index and fever at screening.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the multivariable analysis show about vaccination?",{"text":121,"@type":113},"Influenza vaccination was significantly associated with reduced lower respiratory tract disease risk and was also associated with decreased hospitalization risk.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},460837,1790794337,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","Open Forum Infectious Diseases  \nMAJOR ARTICLE  \nVaccination as a Key Determinant of Influenza Disease Severity in Allogeneic Hematopoietic Stem Cell Transplant Recipients: An Observational Retrospective Study  \nClara Isabel Martínez-López,1 Pedro Chorão,2, Ariadna Pérez,1 Brais Lamas,2 Dolores Gómez,3, Carlos Solano de la Asunción,4 Jaime Sanz,2 Juan Carlos Hernández-Boluda,1,5 David Navarro,4,6 Juan Montoro,2 Carlos Solano,1,5 and José Luis Piñana1,  \n1Department of Hematology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain, 2Hematology Division, Hospital Universitario y Politécnico La Fe, Valencia, Spain, 3Microbiology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain, 4Microbiology Service, Hospital Clínico Universitario, Valencia, Spain, 5Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain, and 6Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain  \nBackground. Influenza virus infection remains a major cause of morbidity in allogeneic hematopoietic stem cell transplant (allo-HCT) recipients. Vaccination is a key preventive strategy; yet, clinical evidence of its benefit in this population is limited.  \nMethods. We conducted a retrospective, multicenter observational study including adult allo-HCT recipients (≥16 years) who developed laboratory-confirmed influenza infection between 2013 and 2023, with the aim of assessing the impact of vaccination on influenza disease severity. Vaccinated status was defined as having received the seasonal influenza vaccine during the same season and before the onset of influenza infection.  \nResults. A total of 143 recipients with 214 influenza episodes were analyzed. The median age was 45 years (range 18–70), and 58% had acute leukemia or myeloid malignancies. Most (64.3%) received transplants from unrelated or haploidentical family donors. Overall, 48 episodes (22%) occurred after influenza vaccination. At infection onset, 52% of vaccinated recipients were profoundly immunosuppressed (within \u003C6 months post-transplant, experiencing active graft-versus-host disease, or receiving immunosuppressors or corticosteroids) . Progression to lower respiratory tract disease (LRTD) occurred in 29% of episodes. Multivariable analysis showed influenza vaccination was significantly associated with reduced LRTD risk (HR 0.18; 95% CI: 0.06–0.50; P = .001), while a high-risk immunodeficiency scoring index (ISI) (HR 4.71; 95% CI: 1.99–11.17; P = .0004) and fever at screening (HR 2.16; 95% CI: 1.51–3.08; P \u003C .001) independently predicted higher LRTD risk. Vaccination was also associated with decreased hospitalization risk (OR 0.20; 95% CI: 0.05–0.57; P = .005); whereas, high-risk ISI was linked to higher admission risk (OR 22.86; 95% CI: 4.82–170, P = .0003) .  \nConclusions. This study provides real-world evidence that seasonal influenza vaccination may reduce disease severity in alloHCT recipients and confirms the prognostic value of the ISI for disease risk assessment.  \nKeywords. allo-HCT; community acquired respiratory virus (CARV); immunodeficiency scoring index (ISI); inactivated influenza vaccine; influenza virus.  \nHighlights  \n• Seasonal influenza vaccination significantly reduces LRTD progression and hospitalization in allo-HCT recipients.  \n• ISI at diagnosis independently predicts LRTD progression, hospital admission and oxygen requirements.  \n• Fever at respiratory virus screening is a good surrogate marker of LRTD progression.  \nReceived 06 October 2025; accepted 15 December 2025; published online 31 December 2025  \nCorrespondence: Jose Luis Piñana PhD, Division of Clinical Hematology, Hospital Clínico Universitario de Valencia, Avda. Blasco Ibáñez 17, Valencia 46010, Valencian Community, Spain (j[lpinana@gmail.com](lpinana@gmail.com)) .  \nOpen Forum Infectious Diseases®  \n© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Dise","cbCaigCsyPK0isO9","https://ap.wps.com/l/cbCaigCsyPK0isO9","pdf",550236,14,"English","# Background\n# Methods\n# Results\n## Disease severity and risk factors\n# Conclusions\n# Highlights\n# Publication details","[{\"question\":\"How was vaccination status defined in the study?\",\"answer\":\"Vaccinated status required receiving the seasonal influenza vaccine during the same season and before the onset of influenza infection.\"},{\"question\":\"What main outcomes were assessed to evaluate disease severity?\",\"answer\":\"The study evaluated progression to lower respiratory tract disease and hospitalization risk, alongside independent predictors such as immunodeficiency scoring index and fever at screening.\"},{\"question\":\"What did the multivariable analysis show about vaccination?\",\"answer\":\"Influenza vaccination was significantly associated with reduced lower respiratory tract disease risk and was also associated with decreased hospitalization risk.\"}]","Vaccination as a Key Determinant of Influenza Disease Severity in Allogeneic Hematopoietic Stem Cell Transplant Recipients - An Observational Retrospective Study | PDF",1790759810,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/002b35e825f75f659d43963b93978d8d.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/1c152666c2d69a745da78ad297cab971.webp",982,1294,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/135016c054e7b900a22e88481ecf029d.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/2164a3fbec5e454657ad4257e5289bf6.webp",980,1292]